Adar Poonawalla has confirmed that Serum Institute of India has applied for emergency use authorisation for Covishield coronavirus vaccine. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD. This will save countless lives, and I thank the Government of India and Sri@narendramodiji for their invaluable support,” the CEO of Serum Institute of India said in a tweet.
Serum Institute of India, the world’s largest vaccine producer by volume, had sought emergency use authorization in the country for AstraZeneca Plc’s COVID-19 vaccine on Sunday, Press Trust of India had reported earlier, citing sources.
The company applied to the Drugs Controller General of India, citing unmet medical needs due to the pandemic and in the interest of the public at large, the report said. The move comes close on the heels of Pfizer Inc applying for a similar authorization of its coronavirus vaccine in India on Saturday.
Prime Minister Narendra Modi visited the Serum Institute of India facility in Pune on 28 November to review vaccine development. “Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility,” PM Modi had tweeted.
Also Read : BHARAT BANDH ON DEC 8: FARMERS GET SUPPORT FROM LEFT PARTIES, TRADE UNIONS
